Gene · 1902
Papers2,112
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,112
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Melanocortin therapies to resolve fibroblast-mediated diseases. | Front Immunol | 2022 | 36793548 | PubTator, text mining | PubMed |
| RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer. | Front Cell Dev Biol | 2022 | 36684450 | PubTator, text mining | PubMed |
| Identifying the mechanisms and molecular targets of Hongjingtian injection on treatment of TGFβ1-induced HK-2 cells: coupling network pharmacology with experimental verification. | Ann Transl Med | 2022 | 36660701 | PubTator, text mining | PubMed |
Lysophosphatidic acid suppresses apoptosis of high-grade serous ovarian cancer cells by inducing autophagy activity and promotes cell-cycle progression via EGFR-PI3K/Aurora-AThr288-geminin dual signaling pathways. | Front Pharmacol | 2022 | 36601056 | PubTator, text mining | PubMed |
| A narrative review for platelets and their RNAs in cancers: New concepts and clinical perspectives. | Medicine (Baltimore) | 2022 | 36596034 | PubTator, text mining | PubMed |
| In vitro evaluation of immunomodulatory, anti-diabetic, and anti-cancer molecular mechanisms of Tribulus terrestris extracts. | Sci Rep | 2022 | 36577761 | PubTator, text mining | PubMed |
| LPA receptor 1 (LPAR1) is a novel interaction partner of Filamin A that promotes Filamin A phosphorylation, MRTF-A transcriptional activity and oncogene-induced senescence. | Oncogenesis | 2022 | 36577757 | PubTator, text mining | PubMed |
| Modulations of bioactive lipids and their receptors in postmortem Alzheimer's disease brains. | Front Aging Neurosci | 2022 | 36570536 | PubTator, text mining | PubMed |
| The Role of Sphingolipids in the Pathogenesis of Psoriasis. | Metabolites | 2022 | 36557209 | PubTator, text mining | PubMed |
| PRLR and CACNA2D1 Impact the Prognosis of Breast Cancer by Regulating Tumor Immunity. | J Pers Med | 2022 | 36556307 | PubTator, text mining | PubMed |
| Features of Lipid Metabolism Disorders in Primary Biliary Cholangitis. | Biomedicines | 2022 | 36551803 | PubTator, text mining | PubMed |
| Alteration of Cellular Energy Metabolism through LPAR2-Axin2 Axis in Gastric Cancer. | Biomolecules | 2022 | 36551233 | PubTator, text mining | PubMed |
| Checkpoint Kinase 1 (CHK1) Functions as Both a Diagnostic Marker and a Regulator of Epithelial-to-Mesenchymal Transition (EMT) in Triple-Negative Breast Cancer. | Curr Issues Mol Biol | 2022 | 36547059 | PubTator, text mining | PubMed |
| Tissue factor as a new target for tumor therapy-killing two birds with one stone: a narrative review. | Ann Transl Med | 2022 | 36544632 | PubTator, text mining | PubMed |
| Insights into divalent cation regulation and G13-coupling of orphan receptor GPR35. | Cell Discov | 2022 | 36543774 | PubTator, text mining | PubMed |
| Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM). | Cell Death Dis | 2022 | 36543771 | PubTator, text mining | PubMed |
| Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. | J Transl Med | 2022 | 36528667 | PubTator, text mining | PubMed |
| A Novel High-Throughput Screening Method for a Human Multicentric Osteosarcoma-Specific Antibody and Biomarker Using a Phage Display-Derived Monoclonal Antibody. | Cancers (Basel) | 2022 | 36497311 | PubTator, text mining | PubMed |
| Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer's disease. | Front Aging Neurosci | 2022 | 36466600 | PubTator, text mining | PubMed |
| CD97 serves as a novel biomarker of immune cell infiltration in hepatocellular carcinoma. | World J Surg Oncol | 2022 | 36464675 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1902/papers?page=17